Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: United States Clear all

1,022 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200018
200120
200231
200339
200446
200552
200663
200747
200847
200939
201025
201131
201221
201338
201425
201540
201629
201745
201845
201933
202031
202146
202229
202331
202426
202532
202634

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed569
Terminated203
Recruiting100
Active, not recruiting74
Withdrawn35
Unknown status30
Not yet recruiting8
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)66
Eli Lilly and Company37
M.D. Anderson Cancer Center37
Memorial Sloan Kettering Cancer Center29
Alliance for Clinical Trials in Oncology27
Pfizer25
SWOG Cancer Research Network23
AstraZeneca19
Bristol-Myers Squibb18
Novartis Pharmaceuticals18

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung1,022
Lung Neoplasms398
Adenocarcinoma of Lung78
Neoplasms50
Adenocarcinoma, Bronchiolo-Alveolar43
Neoplasm Metastasis43
Small Cell Lung Carcinoma39
Breast Neoplasms37
Melanoma35
Colorectal Neoplasms28

Trials

Showing 1 to 25 of 1,022. Each trial links to its page on Pharma Observatory.

922 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.